

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.73359934 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.86039977 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.86039977 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.60725838 |
| 5 | negative regulation of cell killing (GO:0031342) | 5.52218503 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.52218503 |
| 7 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.29643954 |
| 8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.26511495 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.09041776 |
| 10 | negative T cell selection (GO:0043383) | 5.05317381 |
| 11 | negative thymic T cell selection (GO:0045060) | 5.04356583 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.97921013 |
| 13 | positive thymic T cell selection (GO:0045059) | 4.90809488 |
| 14 | regulation of gamma-delta T cell activation (GO:0046643) | 4.90776788 |
| 15 | response to interleukin-15 (GO:0070672) | 4.59631883 |
| 16 | leukocyte aggregation (GO:0070486) | 4.50086091 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 4.48506198 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 4.48506198 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.48506198 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.48506198 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.48506198 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 4.48506198 |
| 23 | detection of bacterium (GO:0016045) | 4.44142788 |
| 24 | detection of other organism (GO:0098543) | 4.36647004 |
| 25 | cellular response to interleukin-15 (GO:0071350) | 4.34319088 |
| 26 | T cell migration (GO:0072678) | 4.33538934 |
| 27 | positive regulation of B cell differentiation (GO:0045579) | 4.33436699 |
| 28 | regulation of B cell differentiation (GO:0045577) | 4.33348141 |
| 29 | thymic T cell selection (GO:0045061) | 4.27821021 |
| 30 | interferon-gamma production (GO:0032609) | 4.27032375 |
| 31 | neutrophil activation involved in immune response (GO:0002283) | 4.21668890 |
| 32 | B cell receptor signaling pathway (GO:0050853) | 4.21391349 |
| 33 | positive T cell selection (GO:0043368) | 4.16915572 |
| 34 | T cell selection (GO:0045058) | 4.11510904 |
| 35 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.07588124 |
| 36 | regulation of T cell tolerance induction (GO:0002664) | 4.03426666 |
| 37 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.02350453 |
| 38 | mast cell activation (GO:0045576) | 3.85661585 |
| 39 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.82755840 |
| 40 | negative regulation of T cell mediated immunity (GO:0002710) | 3.73902213 |
| 41 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.72476496 |
| 42 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.70843805 |
| 43 | macrophage activation involved in immune response (GO:0002281) | 3.68416273 |
| 44 | tolerance induction (GO:0002507) | 3.67761908 |
| 45 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.66560297 |
| 46 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.62995524 |
| 47 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.62114501 |
| 48 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.59524760 |
| 49 | immunoglobulin mediated immune response (GO:0016064) | 3.56784299 |
| 50 | response to type I interferon (GO:0034340) | 3.54258881 |
| 51 | response to peptidoglycan (GO:0032494) | 3.52588550 |
| 52 | T cell receptor signaling pathway (GO:0050852) | 3.51089053 |
| 53 | NIK/NF-kappaB signaling (GO:0038061) | 3.50047437 |
| 54 | regulation of regulatory T cell differentiation (GO:0045589) | 3.49954978 |
| 55 | response to muramyl dipeptide (GO:0032495) | 3.49353045 |
| 56 | cellular response to type I interferon (GO:0071357) | 3.49124720 |
| 57 | type I interferon signaling pathway (GO:0060337) | 3.49124720 |
| 58 | mature B cell differentiation (GO:0002335) | 3.45737013 |
| 59 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.39081888 |
| 60 | neutrophil activation (GO:0042119) | 3.37473077 |
| 61 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.37040152 |
| 62 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.36152039 |
| 63 | positive regulation of tolerance induction (GO:0002645) | 3.36110714 |
| 64 | T cell homeostasis (GO:0043029) | 3.35569016 |
| 65 | detection of external biotic stimulus (GO:0098581) | 3.35533360 |
| 66 | respiratory burst (GO:0045730) | 3.33430609 |
| 67 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.29241210 |
| 68 | regulation of tolerance induction (GO:0002643) | 3.29219060 |
| 69 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.28695747 |
| 70 | T cell costimulation (GO:0031295) | 3.28196195 |
| 71 | positive regulation of interleukin-2 production (GO:0032743) | 3.26864487 |
| 72 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.26726925 |
| 73 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.26097915 |
| 74 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.23748176 |
| 75 | lymphocyte costimulation (GO:0031294) | 3.23332724 |
| 76 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.22556515 |
| 77 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.21999694 |
| 78 | negative regulation of interleukin-12 production (GO:0032695) | 3.20639217 |
| 79 | germinal center formation (GO:0002467) | 3.19642044 |
| 80 | positive regulation of isotype switching (GO:0045830) | 3.18412913 |
| 81 | leukocyte cell-cell adhesion (GO:0007159) | 3.17278469 |
| 82 | myeloid cell activation involved in immune response (GO:0002275) | 3.16142854 |
| 83 | defense response to protozoan (GO:0042832) | 3.15663342 |
| 84 | regulation of antigen processing and presentation (GO:0002577) | 3.13820747 |
| 85 | myeloid dendritic cell activation (GO:0001773) | 3.13118011 |
| 86 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.11716837 |
| 87 | lymphocyte homeostasis (GO:0002260) | 3.11337332 |
| 88 | cellular extravasation (GO:0045123) | 3.09928812 |
| 89 | response to host immune response (GO:0052572) | 3.09684380 |
| 90 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.09684380 |
| 91 | granulocyte activation (GO:0036230) | 3.08695476 |
| 92 | response to protozoan (GO:0001562) | 3.08209512 |
| 93 | positive regulation of interferon-alpha production (GO:0032727) | 3.05701844 |
| 94 | negative regulation of innate immune response (GO:0045824) | 3.03472763 |
| 95 | mature B cell differentiation involved in immune response (GO:0002313) | 3.03038917 |
| 96 | cellular response to interferon-beta (GO:0035458) | 3.01979259 |
| 97 | regulation of mast cell degranulation (GO:0043304) | 3.01184139 |
| 98 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.00236002 |
| 99 | regulation of response to interferon-gamma (GO:0060330) | 2.99265066 |
| 100 | mast cell degranulation (GO:0043303) | 2.97525734 |
| 101 | mast cell activation involved in immune response (GO:0002279) | 2.97525734 |
| 102 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.97304773 |
| 103 | regulation of interferon-alpha production (GO:0032647) | 2.95700423 |
| 104 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.95409364 |
| 105 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.94428395 |
| 106 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.94067207 |
| 107 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.92172676 |
| 108 | detection of biotic stimulus (GO:0009595) | 2.92095733 |
| 109 | leukocyte degranulation (GO:0043299) | 2.92072637 |
| 110 | positive regulation of antigen processing and presentation (GO:0002579) | 2.91914301 |
| 111 | lymph node development (GO:0048535) | 2.91617766 |
| 112 | positive regulation of granulocyte differentiation (GO:0030854) | 2.89979110 |
| 113 | B cell mediated immunity (GO:0019724) | 2.89690667 |
| 114 | regulation of isotype switching (GO:0045191) | 2.89449203 |
| 115 | activated T cell proliferation (GO:0050798) | 2.89298981 |
| 116 | response to host (GO:0075136) | 2.88411602 |
| 117 | response to host defenses (GO:0052200) | 2.88411602 |
| 118 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.88411602 |
| 119 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.87550642 |
| 120 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.87550642 |
| 121 | regulation of B cell mediated immunity (GO:0002712) | 2.84910147 |
| 122 | natural killer cell activation (GO:0030101) | 2.84607265 |
| 123 | positive regulation of B cell mediated immunity (GO:0002714) | 2.83522117 |
| 124 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.83522117 |
| 125 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.83476071 |
| 126 | B cell homeostasis (GO:0001782) | 2.82559485 |
| 127 | leukocyte homeostasis (GO:0001776) | 2.81898045 |
| 128 | positive regulation of humoral immune response (GO:0002922) | 2.81049592 |
| 129 | negative regulation of phagocytosis (GO:0050765) | 2.80318786 |
| 130 | positive regulation of DNA recombination (GO:0045911) | 2.80093672 |
| 131 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.80011411 |
| 132 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.79723190 |
| 133 | T cell proliferation (GO:0042098) | 2.78874304 |
| 134 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.78115823 |
| 135 | positive regulation of B cell activation (GO:0050871) | 2.77195437 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.13288578 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.10748986 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.56259853 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.01018821 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.83742704 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.70237866 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.47542374 |
| 8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.23608150 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 3.15005178 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.06869324 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.99597830 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.95867826 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.86542325 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.85375944 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.84884761 |
| 16 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.84356710 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.78688532 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.73863909 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.73487342 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.71894838 |
| 21 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.68714773 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 2.59560667 |
| 23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.55717068 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.54505184 |
| 25 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.52722448 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.50259550 |
| 27 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.43116918 |
| 28 | MYB_26560356_Chip-Seq_TH1_Human | 2.40633364 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 2.27734736 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.15654455 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.13040842 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.11809302 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.03013456 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.00748815 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.97171048 |
| 36 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.96146415 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.95940452 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91919758 |
| 39 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.84480572 |
| 40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.80276424 |
| 41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.76838986 |
| 42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.76044920 |
| 43 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74125321 |
| 44 | MAF_26560356_Chip-Seq_TH2_Human | 1.73490255 |
| 45 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71831254 |
| 46 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.70762488 |
| 47 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.61870530 |
| 48 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.58168518 |
| 49 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.54972930 |
| 50 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.52049908 |
| 51 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.48743701 |
| 52 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.45921842 |
| 53 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45159276 |
| 54 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.44065679 |
| 55 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.42163294 |
| 56 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.40404494 |
| 57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35342996 |
| 58 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.35000700 |
| 59 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.34235624 |
| 60 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.31169441 |
| 61 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29335125 |
| 62 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26098623 |
| 63 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22397743 |
| 64 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.21592211 |
| 65 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21154159 |
| 66 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20630053 |
| 67 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19980463 |
| 68 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19363272 |
| 69 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.19143519 |
| 70 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.18299407 |
| 71 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.18266454 |
| 72 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.17845082 |
| 73 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.17521574 |
| 74 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16410860 |
| 75 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.13285409 |
| 76 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09793733 |
| 77 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06783265 |
| 78 | GATA1_22025678_ChIP-Seq_K562_Human | 1.06463820 |
| 79 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05412603 |
| 80 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.04491483 |
| 81 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04381333 |
| 82 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04327977 |
| 83 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.02243814 |
| 84 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01845857 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00994243 |
| 86 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.99568810 |
| 87 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98928624 |
| 88 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.97950759 |
| 89 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.97725309 |
| 90 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.96551668 |
| 91 | P68_20966046_ChIP-Seq_HELA_Human | 0.94854782 |
| 92 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91443545 |
| 93 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90749385 |
| 94 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89120042 |
| 95 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88997387 |
| 96 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.88430682 |
| 97 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86870158 |
| 98 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85520563 |
| 99 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.83597537 |
| 100 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83371137 |
| 101 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.82802152 |
| 102 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.82665320 |
| 103 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82094522 |
| 104 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.82028389 |
| 105 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81861782 |
| 106 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.81192773 |
| 107 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78652710 |
| 108 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.77955233 |
| 109 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.75640072 |
| 110 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.73297874 |
| 111 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.72662457 |
| 112 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.72425251 |
| 113 | GATA1_19941826_ChIP-Seq_K562_Human | 0.72329074 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 0.71595742 |
| 115 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.71473568 |
| 116 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.71360400 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.25892741 |
| 2 | MP0005671_abnormal_response_to | 3.85254077 |
| 3 | MP0000685_abnormal_immune_system | 3.61529998 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.59185317 |
| 5 | MP0001800_abnormal_humoral_immune | 3.38521443 |
| 6 | MP0005387_immune_system_phenotype | 3.19523622 |
| 7 | MP0001790_abnormal_immune_system | 3.19523622 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.97058409 |
| 9 | MP0009785_altered_susceptibility_to | 2.95538086 |
| 10 | MP0002452_abnormal_antigen_presenting | 2.91448421 |
| 11 | MP0002723_abnormal_immune_serum | 2.88061611 |
| 12 | MP0002420_abnormal_adaptive_immunity | 2.83356703 |
| 13 | MP0001819_abnormal_immune_cell | 2.80509325 |
| 14 | MP0003436_decreased_susceptibility_to | 2.79946769 |
| 15 | MP0005025_abnormal_response_to | 2.73021551 |
| 16 | MP0002396_abnormal_hematopoietic_system | 2.70897384 |
| 17 | MP0002398_abnormal_bone_marrow | 2.65335038 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.55245760 |
| 19 | MP0002419_abnormal_innate_immunity | 2.50177469 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.46910036 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.41270571 |
| 22 | MP0000716_abnormal_immune_system | 2.39369494 |
| 23 | MP0001873_stomach_inflammation | 2.34800625 |
| 24 | MP0003303_peritoneal_inflammation | 2.29961908 |
| 25 | MP0006082_CNS_inflammation | 2.27142236 |
| 26 | MP0002405_respiratory_system_inflammati | 2.24928736 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 2.24592128 |
| 28 | MP0000689_abnormal_spleen_morphology | 2.23868791 |
| 29 | MP0002722_abnormal_immune_system | 2.15880142 |
| 30 | MP0002006_tumorigenesis | 2.05079034 |
| 31 | MP0003724_increased_susceptibility_to | 2.04164702 |
| 32 | MP0010155_abnormal_intestine_physiology | 2.00567686 |
| 33 | MP0002429_abnormal_blood_cell | 2.00001794 |
| 34 | MP0004808_abnormal_hematopoietic_stem | 1.99757655 |
| 35 | MP0000703_abnormal_thymus_morphology | 1.93011834 |
| 36 | MP0004947_skin_inflammation | 1.89157935 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.85169052 |
| 38 | MP0003866_abnormal_defecation | 1.84713101 |
| 39 | MP0001853_heart_inflammation | 1.83500195 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.82049374 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.71867751 |
| 42 | MP0004510_myositis | 1.69225421 |
| 43 | MP0005174_abnormal_tail_pigmentation | 1.66251473 |
| 44 | MP0005397_hematopoietic_system_phenotyp | 1.62858959 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.62858959 |
| 46 | MP0009278_abnormal_bone_marrow | 1.61384648 |
| 47 | MP0005451_abnormal_body_composition | 1.58731486 |
| 48 | MP0002933_joint_inflammation | 1.52657146 |
| 49 | MP0008469_abnormal_protein_level | 1.38458371 |
| 50 | MP0005075_abnormal_melanosome_morpholog | 1.35027024 |
| 51 | MP0008260_abnormal_autophagy | 1.31217230 |
| 52 | MP0000490_abnormal_crypts_of | 1.30118055 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.29165480 |
| 54 | MP0005058_abnormal_lysosome_morphology | 1.27200976 |
| 55 | MP0005310_abnormal_salivary_gland | 1.24066428 |
| 56 | MP0000858_altered_metastatic_potential | 1.21793926 |
| 57 | MP0003172_abnormal_lysosome_physiology | 1.18652959 |
| 58 | MP0003191_abnormal_cellular_cholesterol | 1.15096010 |
| 59 | MP0000569_abnormal_digit_pigmentation | 1.06509325 |
| 60 | MP0003448_altered_tumor_morphology | 1.03886356 |
| 61 | MP0003183_abnormal_peptide_metabolism | 1.02251407 |
| 62 | MP0000015_abnormal_ear_pigmentation | 1.01749146 |
| 63 | MP0002019_abnormal_tumor_incidence | 0.96337270 |
| 64 | MP0001851_eye_inflammation | 0.95512949 |
| 65 | MP0009764_decreased_sensitivity_to | 0.92880517 |
| 66 | MP0008057_abnormal_DNA_replication | 0.86859398 |
| 67 | MP0002095_abnormal_skin_pigmentation | 0.83144762 |
| 68 | MP0002132_abnormal_respiratory_system | 0.82688992 |
| 69 | MP0004883_abnormal_blood_vessel | 0.82114289 |
| 70 | MP0002138_abnormal_hepatobiliary_system | 0.81877769 |
| 71 | MP0002009_preneoplasia | 0.81541845 |
| 72 | MP0002998_abnormal_bone_remodeling | 0.81450491 |
| 73 | MP0009763_increased_sensitivity_to | 0.77474742 |
| 74 | MP0000371_diluted_coat_color | 0.76839749 |
| 75 | MP0000343_altered_response_to | 0.75235646 |
| 76 | MP0003045_fibrosis | 0.74268426 |
| 77 | MP0008004_abnormal_stomach_pH | 0.73687256 |
| 78 | MP0003077_abnormal_cell_cycle | 0.72655869 |
| 79 | MP0003693_abnormal_embryo_hatching | 0.72135171 |
| 80 | MP0005023_abnormal_wound_healing | 0.69639588 |
| 81 | MP0003806_abnormal_nucleotide_metabolis | 0.67542104 |
| 82 | MP0000604_amyloidosis | 0.66918848 |
| 83 | MP0001663_abnormal_digestive_system | 0.65838608 |
| 84 | MP0003828_pulmonary_edema | 0.64650933 |
| 85 | MP0005166_decreased_susceptibility_to | 0.64298096 |
| 86 | MP0010352_gastrointestinal_tract_polyps | 0.63554363 |
| 87 | MP0001986_abnormal_taste_sensitivity | 0.62825459 |
| 88 | MP0002277_abnormal_respiratory_mucosa | 0.60587064 |
| 89 | MP0010094_abnormal_chromosome_stability | 0.60144566 |
| 90 | MP0004264_abnormal_extraembryonic_tissu | 0.59763167 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.59164295 |
| 92 | MP0003690_abnormal_glial_cell | 0.58288540 |
| 93 | MP0004381_abnormal_hair_follicle | 0.58286695 |
| 94 | MP0010307_abnormal_tumor_latency | 0.58118940 |
| 95 | MP0000249_abnormal_blood_vessel | 0.57864041 |
| 96 | MP0002928_abnormal_bile_duct | 0.57836341 |
| 97 | MP0009840_abnormal_foam_cell | 0.57798362 |
| 98 | MP0002693_abnormal_pancreas_physiology | 0.57582268 |
| 99 | MP0008058_abnormal_DNA_repair | 0.57152236 |
| 100 | MP0009765_abnormal_xenobiotic_induced | 0.55507013 |
| 101 | MP0000313_abnormal_cell_death | 0.55375187 |
| 102 | MP0005164_abnormal_response_to | 0.55113285 |
| 103 | MP0000477_abnormal_intestine_morphology | 0.54663142 |
| 104 | MP0000609_abnormal_liver_physiology | 0.54344128 |
| 105 | MP0008874_decreased_physiological_sensi | 0.52564872 |
| 106 | MP0005381_digestive/alimentary_phenotyp | 0.52299739 |
| 107 | MP0008007_abnormal_cellular_replicative | 0.51651037 |
| 108 | MP0008961_abnormal_basal_metabolism | 0.51644834 |
| 109 | MP0003795_abnormal_bone_structure | 0.51027435 |
| 110 | MP0003091_abnormal_cell_migration | 0.48057459 |
| 111 | MP0003075_altered_response_to | 0.47984716 |
| 112 | MP0005390_skeleton_phenotype | 0.46618169 |
| 113 | MP0003943_abnormal_hepatobiliary_system | 0.45761947 |
| 114 | MP0003656_abnormal_erythrocyte_physiolo | 0.45423994 |
| 115 | MP0003453_abnormal_keratinocyte_physiol | 0.45324430 |
| 116 | MP0004185_abnormal_adipocyte_glucose | 0.44534583 |
| 117 | MP0003252_abnormal_bile_duct | 0.42259391 |
| 118 | MP0009115_abnormal_fat_cell | 0.42075135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.17849374 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.06709799 |
| 3 | Myositis (HP:0100614) | 4.81841051 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.66819019 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.62354224 |
| 6 | Recurrent fungal infections (HP:0002841) | 4.57875344 |
| 7 | Recurrent viral infections (HP:0004429) | 4.52582043 |
| 8 | IgM deficiency (HP:0002850) | 4.46582092 |
| 9 | T lymphocytopenia (HP:0005403) | 4.43973332 |
| 10 | Abnormality of T cell number (HP:0011839) | 4.29952583 |
| 11 | Recurrent bronchitis (HP:0002837) | 4.28254139 |
| 12 | Panhypogammaglobulinemia (HP:0003139) | 4.24885865 |
| 13 | Chronic otitis media (HP:0000389) | 4.21756546 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.03470504 |
| 15 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.01836868 |
| 16 | Recurrent cutaneous fungal infections (HP:0011370) | 4.01836868 |
| 17 | Pustule (HP:0200039) | 3.84638267 |
| 18 | Agammaglobulinemia (HP:0004432) | 3.82791284 |
| 19 | Abnormality of T cells (HP:0002843) | 3.80692226 |
| 20 | Recurrent skin infections (HP:0001581) | 3.74536452 |
| 21 | Meningitis (HP:0001287) | 3.64288005 |
| 22 | Stomatitis (HP:0010280) | 3.61694457 |
| 23 | Inflammation of the large intestine (HP:0002037) | 3.48377189 |
| 24 | Nasal polyposis (HP:0100582) | 3.47898172 |
| 25 | Thrombocytosis (HP:0001894) | 3.47891370 |
| 26 | Lymphopenia (HP:0001888) | 3.40392942 |
| 27 | Gastrointestinal inflammation (HP:0004386) | 3.39307580 |
| 28 | Vasculitis (HP:0002633) | 3.37925693 |
| 29 | Abnormality of the fingertips (HP:0001211) | 3.37359491 |
| 30 | Mediastinal lymphadenopathy (HP:0100721) | 3.36703041 |
| 31 | Autoimmune thrombocytopenia (HP:0001973) | 3.34116088 |
| 32 | Thyroiditis (HP:0100646) | 3.32994849 |
| 33 | Severe combined immunodeficiency (HP:0004430) | 3.31582655 |
| 34 | Optic neuritis (HP:0100653) | 3.30991982 |
| 35 | Retrobulbar optic neuritis (HP:0100654) | 3.30991982 |
| 36 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.26735141 |
| 37 | Colitis (HP:0002583) | 3.23506661 |
| 38 | Orchitis (HP:0100796) | 3.21823431 |
| 39 | Combined immunodeficiency (HP:0005387) | 3.17574414 |
| 40 | Chronic diarrhea (HP:0002028) | 3.13563868 |
| 41 | Abnormality of T cell physiology (HP:0011840) | 3.13518280 |
| 42 | Abnormality of the nasal mucosa (HP:0000433) | 3.13335215 |
| 43 | Cellulitis (HP:0100658) | 3.13287185 |
| 44 | Prolonged bleeding time (HP:0003010) | 3.13195535 |
| 45 | Urticaria (HP:0001025) | 3.10303430 |
| 46 | Abnormality of B cell number (HP:0010975) | 3.05666117 |
| 47 | B lymphocytopenia (HP:0010976) | 3.05666117 |
| 48 | IgG deficiency (HP:0004315) | 3.05651026 |
| 49 | Leukocytosis (HP:0001974) | 3.05548032 |
| 50 | Gastrointestinal stroma tumor (HP:0100723) | 3.02881699 |
| 51 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.02409296 |
| 52 | Increased IgM level (HP:0003496) | 2.99979715 |
| 53 | Chronic obstructive pulmonary disease (HP:0006510) | 2.95953037 |
| 54 | Obstructive lung disease (HP:0006536) | 2.95953037 |
| 55 | Spontaneous hematomas (HP:0007420) | 2.93123023 |
| 56 | Recurrent sinusitis (HP:0011108) | 2.89342746 |
| 57 | Abnormality of macrophages (HP:0004311) | 2.87841200 |
| 58 | Eosinophilia (HP:0001880) | 2.83861548 |
| 59 | Abnormality of eosinophils (HP:0001879) | 2.83776210 |
| 60 | Encephalitis (HP:0002383) | 2.82159651 |
| 61 | Petechiae (HP:0000967) | 2.81525992 |
| 62 | Epistaxis (HP:0000421) | 2.80929197 |
| 63 | Hypochromic anemia (HP:0001931) | 2.70043797 |
| 64 | Arterial thrombosis (HP:0004420) | 2.68748050 |
| 65 | Granulocytopenia (HP:0001913) | 2.66359456 |
| 66 | Hemoptysis (HP:0002105) | 2.59334610 |
| 67 | Periodontitis (HP:0000704) | 2.54952046 |
| 68 | Pulmonary infiltrates (HP:0002113) | 2.54211665 |
| 69 | IgA deficiency (HP:0002720) | 2.51657735 |
| 70 | Increased IgE level (HP:0003212) | 2.49257561 |
| 71 | Gingival bleeding (HP:0000225) | 2.48122307 |
| 72 | Impaired platelet aggregation (HP:0003540) | 2.46920517 |
| 73 | Abnormal platelet function (HP:0011869) | 2.46920517 |
| 74 | Lymphoma (HP:0002665) | 2.43576796 |
| 75 | Autoimmune hemolytic anemia (HP:0001890) | 2.43420078 |
| 76 | Pulmonary embolism (HP:0002204) | 2.42062335 |
| 77 | Vacuolated lymphocytes (HP:0001922) | 2.40060078 |
| 78 | Bronchitis (HP:0012387) | 2.39501579 |
| 79 | Chest pain (HP:0100749) | 2.38443394 |
| 80 | Gingivitis (HP:0000230) | 2.38298532 |
| 81 | Episodic fever (HP:0001954) | 2.37926398 |
| 82 | Emphysema (HP:0002097) | 2.37228060 |
| 83 | Keratoconjunctivitis sicca (HP:0001097) | 2.35537199 |
| 84 | Papilloma (HP:0012740) | 2.32381740 |
| 85 | Verrucae (HP:0200043) | 2.32381740 |
| 86 | Chronic sinusitis (HP:0011109) | 2.32146328 |
| 87 | Interstitial pulmonary disease (HP:0006530) | 2.31470851 |
| 88 | Hypochromic microcytic anemia (HP:0004840) | 2.29059417 |
| 89 | Joint swelling (HP:0001386) | 2.24210483 |
| 90 | Anorexia (HP:0002039) | 2.22083437 |
| 91 | Fatigue (HP:0012378) | 2.20533158 |
| 92 | Hypoplasia of the thymus (HP:0000778) | 2.18285801 |
| 93 | Abnormality of the pleura (HP:0002103) | 2.16790694 |
| 94 | Purpura (HP:0000979) | 2.16017881 |
| 95 | Osteomyelitis (HP:0002754) | 2.14510647 |
| 96 | Viral hepatitis (HP:0006562) | 2.12098451 |
| 97 | Keratoconjunctivitis (HP:0001096) | 2.11979344 |
| 98 | Skin ulcer (HP:0200042) | 2.10542679 |
| 99 | Papilledema (HP:0001085) | 2.10415215 |
| 100 | Cheilitis (HP:0100825) | 2.10350128 |
| 101 | Hypergammaglobulinemia (HP:0010702) | 2.10045312 |
| 102 | Gangrene (HP:0100758) | 2.09158733 |
| 103 | Gastrointestinal infarctions (HP:0005244) | 2.08911762 |
| 104 | Restrictive lung disease (HP:0002091) | 2.07671521 |
| 105 | Recurrent pneumonia (HP:0006532) | 2.06117924 |
| 106 | Skin rash (HP:0000988) | 2.03761511 |
| 107 | Abnormality of the prostate (HP:0008775) | 2.03737454 |
| 108 | Premature loss of primary teeth (HP:0006323) | 2.03516994 |
| 109 | Hematochezia (HP:0002573) | 2.01096132 |
| 110 | Slow saccadic eye movements (HP:0000514) | 1.99139403 |
| 111 | Microcytic anemia (HP:0001935) | 1.97670843 |
| 112 | Increased serum ferritin (HP:0003281) | 1.96842717 |
| 113 | Recurrent lower respiratory tract infections (HP:0002783) | 1.96619569 |
| 114 | Amaurosis fugax (HP:0100576) | 1.96003372 |
| 115 | Systemic lupus erythematosus (HP:0002725) | 1.95544346 |
| 116 | Sepsis (HP:0100806) | 1.94585172 |
| 117 | Arthralgia (HP:0002829) | 1.92900714 |
| 118 | Increased cerebral lipofuscin (HP:0011813) | 1.91602947 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.89130355 |
| 2 | TXK | 3.95748628 |
| 3 | JAK3 | 2.96476005 |
| 4 | PRPF4B | 2.92975282 |
| 5 | ZAP70 | 2.80787463 |
| 6 | TYK2 | 2.80122335 |
| 7 | KIT | 2.59182922 |
| 8 | IKBKE | 2.51413310 |
| 9 | BLK | 2.42726820 |
| 10 | TBK1 | 2.23640169 |
| 11 | STK10 | 2.23089167 |
| 12 | MAP3K14 | 2.20792679 |
| 13 | IRAK4 | 2.20007798 |
| 14 | ITK | 2.19732315 |
| 15 | BTK | 2.19279474 |
| 16 | MAP3K13 | 2.01726397 |
| 17 | JAK1 | 2.01710517 |
| 18 | FGFR4 | 2.01381373 |
| 19 | CSF1R | 1.97066042 |
| 20 | TEC | 1.92451028 |
| 21 | SYK | 1.91526420 |
| 22 | TGFBR2 | 1.86531748 |
| 23 | GRK6 | 1.84615718 |
| 24 | LCK | 1.78606247 |
| 25 | SIK2 | 1.72347525 |
| 26 | MAP3K10 | 1.67847836 |
| 27 | RIPK4 | 1.63678869 |
| 28 | HCK | 1.56967214 |
| 29 | IKBKB | 1.56194914 |
| 30 | EEF2K | 1.48415257 |
| 31 | CSK | 1.43238658 |
| 32 | IRAK3 | 1.42077145 |
| 33 | FES | 1.33229611 |
| 34 | FGFR3 | 1.30392709 |
| 35 | NLK | 1.27944484 |
| 36 | MAP3K3 | 1.27165921 |
| 37 | SMG1 | 1.24256236 |
| 38 | LYN | 1.21869374 |
| 39 | MARK3 | 1.18980388 |
| 40 | NME2 | 1.14939112 |
| 41 | FGR | 1.12402034 |
| 42 | PIM1 | 1.11629994 |
| 43 | LRRK2 | 1.10381817 |
| 44 | TAOK3 | 1.10073794 |
| 45 | MAP2K3 | 1.09013319 |
| 46 | CLK1 | 1.06937510 |
| 47 | ERN1 | 1.06462141 |
| 48 | SIK3 | 1.06417951 |
| 49 | RPS6KA4 | 1.02408568 |
| 50 | MAP3K1 | 1.01165572 |
| 51 | FLT3 | 0.97818795 |
| 52 | CHUK | 0.95237726 |
| 53 | PASK | 0.93545847 |
| 54 | JAK2 | 0.88705570 |
| 55 | CDC42BPA | 0.84071427 |
| 56 | TAOK2 | 0.83080079 |
| 57 | MAP2K2 | 0.78864550 |
| 58 | EPHB1 | 0.78700213 |
| 59 | PRKCQ | 0.75654091 |
| 60 | TGFBR1 | 0.72885351 |
| 61 | KDR | 0.72676289 |
| 62 | CDK12 | 0.68594788 |
| 63 | BMPR2 | 0.68410712 |
| 64 | PRKCH | 0.68393460 |
| 65 | TNK2 | 0.65900019 |
| 66 | CAMKK1 | 0.65377060 |
| 67 | PKN2 | 0.65275887 |
| 68 | CDK19 | 0.65112946 |
| 69 | MAP3K7 | 0.63510338 |
| 70 | NEK2 | 0.61649116 |
| 71 | KSR2 | 0.61409783 |
| 72 | IRAK1 | 0.60095742 |
| 73 | PDPK1 | 0.59494751 |
| 74 | CDK4 | 0.56984678 |
| 75 | STK4 | 0.53699752 |
| 76 | MAPK11 | 0.50814197 |
| 77 | PDK1 | 0.48332751 |
| 78 | MST4 | 0.47934205 |
| 79 | HIPK2 | 0.47018057 |
| 80 | TESK2 | 0.45452834 |
| 81 | DYRK1B | 0.45087971 |
| 82 | TRPM7 | 0.44814187 |
| 83 | MAP3K12 | 0.44499288 |
| 84 | BRD4 | 0.43130026 |
| 85 | TRIB3 | 0.43031821 |
| 86 | RPS6KC1 | 0.42163852 |
| 87 | RPS6KL1 | 0.42163852 |
| 88 | CAMK1D | 0.41682391 |
| 89 | IRAK2 | 0.41441808 |
| 90 | MAPK12 | 0.40499855 |
| 91 | CAMK1G | 0.39979238 |
| 92 | PRKD2 | 0.37997159 |
| 93 | PIM2 | 0.37065251 |
| 94 | MAPK4 | 0.36539570 |
| 95 | SGK3 | 0.36504566 |
| 96 | MAPK7 | 0.34686565 |
| 97 | ABL1 | 0.34649542 |
| 98 | PTK6 | 0.34509741 |
| 99 | RPS6KA6 | 0.33885071 |
| 100 | CDK6 | 0.32979037 |
| 101 | MELK | 0.32330686 |
| 102 | TAOK1 | 0.32311273 |
| 103 | STK11 | 0.32134656 |
| 104 | MATK | 0.31788752 |
| 105 | CAMKK2 | 0.30746866 |
| 106 | ADRBK2 | 0.30511035 |
| 107 | SIK1 | 0.30100823 |
| 108 | RET | 0.30063795 |
| 109 | MAPKAPK2 | 0.29907561 |
| 110 | NEK9 | 0.29764008 |
| 111 | BMX | 0.29471701 |
| 112 | TTN | 0.29460592 |
| 113 | IGF1R | 0.29034092 |
| 114 | YES1 | 0.28422340 |
| 115 | MARK2 | 0.28387722 |
| 116 | EGFR | 0.27971554 |
| 117 | PDGFRB | 0.27767257 |
| 118 | FYN | 0.27487595 |
| 119 | CDK9 | 0.27277105 |
| 120 | ATR | 0.26618015 |
| 121 | PRKCD | 0.26052343 |
| 122 | MAPK3 | 0.24979587 |
| 123 | MAP3K5 | 0.24657721 |
| 124 | PIK3CG | 0.24521872 |
| 125 | MAP3K11 | 0.24181187 |
| 126 | EPHA3 | 0.24143101 |
| 127 | RPS6KB2 | 0.23986561 |
| 128 | MAP2K6 | 0.22503369 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.56625884 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.74466916 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.67711273 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.67614528 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.65190757 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.64928712 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.57414645 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.48685513 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.47388172 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.44554277 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.35377194 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.12141435 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.99047389 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.98690758 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 1.95324561 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.92162861 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.89515247 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.84751473 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.84093511 |
| 20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.82036473 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.72503461 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.70360505 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.53433573 |
| 24 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.53271342 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46911119 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.46364041 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.38101654 |
| 28 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.37670877 |
| 29 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.35499502 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.34462554 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.34133459 |
| 32 | Pertussis_Homo sapiens_hsa05133 | 1.32448430 |
| 33 | Hepatitis B_Homo sapiens_hsa05161 | 1.31257825 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.27411239 |
| 35 | Legionellosis_Homo sapiens_hsa05134 | 1.24779824 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.23761979 |
| 37 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.22599916 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.20922037 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.18538868 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.17801499 |
| 41 | Malaria_Homo sapiens_hsa05144 | 1.15397237 |
| 42 | Asthma_Homo sapiens_hsa05310 | 1.12472489 |
| 43 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.12240867 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.09859246 |
| 45 | Ribosome_Homo sapiens_hsa03010 | 1.04671943 |
| 46 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.01256089 |
| 47 | Base excision repair_Homo sapiens_hsa03410 | 1.00335806 |
| 48 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.00180318 |
| 49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.00138078 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.98002134 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 0.96394224 |
| 52 | DNA replication_Homo sapiens_hsa03030 | 0.95069809 |
| 53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.94724032 |
| 54 | Salmonella infection_Homo sapiens_hsa05132 | 0.89096047 |
| 55 | Phagosome_Homo sapiens_hsa04145 | 0.87454710 |
| 56 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.84568598 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83491190 |
| 58 | HTLV-I infection_Homo sapiens_hsa05166 | 0.81411412 |
| 59 | Mismatch repair_Homo sapiens_hsa03430 | 0.80874462 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80807822 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74416449 |
| 62 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.73372706 |
| 63 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.72417835 |
| 64 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.72262679 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71781248 |
| 66 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.66097254 |
| 67 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.66030276 |
| 68 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.65287107 |
| 69 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61797326 |
| 70 | Lysosome_Homo sapiens_hsa04142 | 0.61518074 |
| 71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61319015 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59505236 |
| 73 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59337840 |
| 74 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59013385 |
| 75 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.58186702 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57998922 |
| 77 | Colorectal cancer_Homo sapiens_hsa05210 | 0.55492170 |
| 78 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55169521 |
| 79 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54387755 |
| 80 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.53435148 |
| 81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49561377 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49360082 |
| 83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49331678 |
| 84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47929123 |
| 85 | Homologous recombination_Homo sapiens_hsa03440 | 0.46451860 |
| 86 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46440652 |
| 87 | Spliceosome_Homo sapiens_hsa03040 | 0.46026590 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45971915 |
| 89 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.45590820 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45496875 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42473628 |
| 92 | ABC transporters_Homo sapiens_hsa02010 | 0.41217173 |
| 93 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.38516290 |
| 94 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38371550 |
| 95 | Prostate cancer_Homo sapiens_hsa05215 | 0.37792584 |
| 96 | RNA degradation_Homo sapiens_hsa03018 | 0.37485615 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.37398289 |
| 98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37112500 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37087937 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.35709475 |
| 101 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35042480 |
| 102 | Thyroid cancer_Homo sapiens_hsa05216 | 0.30922281 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30103765 |
| 104 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.30057935 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29980185 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29928895 |
| 107 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.28316400 |
| 108 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.27441067 |
| 109 | Amoebiasis_Homo sapiens_hsa05146 | 0.22340229 |
| 110 | Lysine degradation_Homo sapiens_hsa00310 | 0.21935239 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21708357 |
| 112 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.21659368 |
| 113 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.21420227 |
| 114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.21016848 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.20963666 |
| 116 | Pathways in cancer_Homo sapiens_hsa05200 | 0.20644058 |
| 117 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.20638540 |
| 118 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.20437851 |
| 119 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.19645702 |
| 120 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.18775826 |
| 121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.16141069 |
| 122 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.15840119 |

